Home » Stocks » UTMD

Utah Medical Products, Inc. (UTMD)

Stock Price: $88.74 USD 0.05 (0.06%)
Updated Jul 28, 2021 4:00 PM EDT - Market closed
Market Cap 322.14M
Revenue (ttm) 42.24M
Net Income (ttm) 10.68M
Shares Out 3.64M
EPS (ttm) 3.50
PE Ratio 25.34
Forward PE n/a
Dividend $1.13
Dividend Yield 1.27%
Trading Day July 28
Last Price $88.74
Previous Close $88.69
Change ($) 0.05
Change (%) 0.06%
Day's Open 88.52
Day's Range 87.00 - 88.74
Day's Volume 5,813
52-Week Range 76.21 - 95.03

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Salt Lake City, Utah, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results we...

6 days ago - GlobeNewsWire

SALT LAKE CITY, UT / ACCESSWIRE / May 11, 2021 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($....

2 months ago - Accesswire

Salt Lake City, Utah, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Because of the aberration in results which began in March 2020 due to the impact of restrictions on “nonessential” medical pr...

3 months ago - GlobeNewsWire

Salt Lake City, UT, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) reports financ...

9 months ago - GlobeNewsWire

Salt Lake City, Utah, July 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- As many of the gynecology devices provided by Utah Medical Products, Inc. (Nasdaq: UTMD) are used in “nonessential” or “elec...

1 year ago - GlobeNewsWire

Salt Lake City, Utah, April 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- In the first calendar quarter (1Q) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with 1Q ...

1 year ago - GlobeNewsWire

Searching For Wonderful Businesses: Utah Medical Products

1 year ago - Seeking Alpha

Salt Lake City, UT, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- As stockholders of Utah Medical Products, Inc. (Nasdaq: UTMD) appreciate, as a result of the recent rapid spread of the COVID...

1 year ago - GlobeNewsWire

Utah-based Utah Medical Products (NASDAQ:UTMD) develops, manufactures and markets a broad spectrum of disposable and reusable specialty medical devices, primarily focusing on products for women and newb...

1 year ago - GuruFocus

To have more of a chance to unearth high-quality companies, Benjamin Graham, the pioneer of value investing, suggested selecting stocks with a current ratio of more than two and higher working capital t...

Other stocks mentioned: EGOV, SHOO
1 year ago - GuruFocus

Salt Lake City, Utah, Oct. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – In the third calendar quarter (3Q) and first nine months (9M) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained re...

1 year ago - GlobeNewsWire

Utah Medical Products Inc. invents, innovates, designs, engineers, manufactures, and sells quality medical instruments to end-users and third party distributors for use in hospital and office settings.

2 years ago - Seeking Alpha

About UTMD

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE l... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1978
CEO
Kevin Cornwell
Employees
181
Stock Exchange
NASDAQ
Ticker Symbol
UTMD
Full Company Profile

Financial Performance

In 2020, UTMD's revenue was $42.18 million, a decrease of -10.08% compared to the previous year's $46.90 million. Earnings were $10.80 million, a decrease of -26.68%.

Financial Statements